{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T15:30:16Z","timestamp":1769873416334,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.vaccine.2004.07.042","type":"journal-article","created":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T18:24:21Z","timestamp":1095791061000},"page":"977-983","source":"Crossref","is-referenced-by-count":30,"title":["Naturally-acquired immunity to Neisseria meningitidis group A"],"prefix":"10.1016","volume":"23","author":[{"given":"Jacob","family":"Amir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesile","family":"Louie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan M.","family":"Granoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2004.07.042_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2004.07.042_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.med.55.091902.103612","article-title":"Opportunities for control of meningococcal disease in the United States","volume":"55","author":"Raghunathan","year":"2004","journal-title":"Annu Rev Med"},{"issue":"8390","key":"10.1016\/j.vaccine.2004.07.042_bib3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(84)91830-0","article-title":"Meningococcal disease and season in sub-Saharan Africa","volume":"1","author":"Greenwood","year":"1984","journal-title":"Lancet"},{"issue":"31","key":"10.1016\/j.vaccine.2004.07.042_bib4","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1016\/S0264-410X(01)00205-5","article-title":"Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting, 2000 October 6\u20138, Vienna, Austria","volume":"19","author":"Cartwright","year":"2001","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2004.07.042_bib5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(02)00455-3","article-title":"Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso","volume":"2","author":"Decosas","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"9320","key":"10.1016\/j.vaccine.2004.07.042_bib6","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2004.07.042_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/341067","article-title":"Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease","volume":"186","author":"Kellerman","year":"2002","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2004.07.042_bib8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/IAI.6.5.651-656.1972","article-title":"Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3","volume":"6","author":"Robbins","year":"1972","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2004.07.042_bib9","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/IAI.13.6.1654-1662.1976","article-title":"Bacillus pumilus polysaccharide cross-reactive with meningococcal group A polysaccharide","volume":"13","author":"Vann","year":"1976","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2004.07.042_bib10","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.162.6.1837","article-title":"Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis","volume":"162","author":"Guirguis","year":"1985","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2004.07.042_bib11","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcusI","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2004.07.042_bib12","doi-asserted-by":"crossref","unstructured":"Ismail, AA, Harris, SL, Granoff, DM. Serum group A anticapsular antibodies in a Sudanese population immunized with meningococcal polysaccharide vaccine during a group A epidemic. Pediatr Infect Dis J 2004;23(8):748\u201355.","DOI":"10.1097\/01.inf.0000135659.52662.a2"},{"issue":"1","key":"10.1016\/j.vaccine.2004.07.042_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1017\/S0950268899003398","article-title":"Management of an outbreak of meningococcal meningitis in a Sudanese refugee camp in Northern Uganda","volume":"124","author":"Santaniello-Newton","year":"2000","journal-title":"Epidemiol Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2004.07.042_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/00034989760536","article-title":"Meningococcal disease in Africa","volume":"91","author":"Hart","year":"1997","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2004.07.042_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0022-3476(96)70389-X","article-title":"Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children","volume":"128","author":"King","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2004.07.042_bib16","doi-asserted-by":"crossref","unstructured":"Granoff, DM, Harris, SL. Protective activity of group C anticapsular antibodies elicited in 2 year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid vonjugate vaccine. Pediatr Infect Dis J 2004;23 (in press).","DOI":"10.1097\/01.inf.0000129686.12470.e6"},{"issue":"6","key":"10.1016\/j.vaccine.2004.07.042_bib17","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1128\/IAI.71.6.3402-3408.2003","article-title":"Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid Conjugate vaccine and by a polysaccharide vaccine","volume":"71","author":"Harris","year":"2003","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2004.07.042_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/CDLI.2.2.132-137.1995","article-title":"Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992","volume":"2","author":"Holder","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2004.07.042_bib19","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1128\/IAI.60.12.5267-5282.1992","article-title":"Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China","volume":"60","author":"Wang","year":"1992","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2004.07.042_bib20","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.4049\/jimmunol.172.9.5606","article-title":"Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine","volume":"172","author":"Welsch","year":"2004","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2004.07.042_bib21","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4049\/jimmunol.147.6.1962","article-title":"Human IgA1 blockade of IgG-initiated lysis of Neisseria meningitidis is a function of antigen-binding fragment binding to the polysaccharide capsule","volume":"147","author":"Jarvis","year":"1991","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2004.07.042_bib22","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.4049\/jimmunol.114.6.1779","article-title":"Bactericidal activity of meningococcal antisera","volume":"114","author":"Griffiss","year":"1975","journal-title":"J Immunol"},{"issue":"31","key":"10.1016\/j.vaccine.2004.07.042_bib23","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1016\/S0264-410X(01)00209-2","article-title":"Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States","volume":"19","author":"Lingappa","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.07.042_bib24","unstructured":"Granoff, D, Feavers, I, Borrow, R. Meningococcal Vaccines. In: Plotkin, SA, Orenstein, WA, editors.Vaccines. W. B. Saunders Company, Philadelphia, 2003."},{"issue":"11","key":"10.1016\/j.vaccine.2004.07.042_bib25","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.267.11.1489","article-title":"bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines","volume":"267","author":"Schlesinger","year":"1992","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.vaccine.2004.07.042_bib26","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1128\/IAI.67.5.2366-2370.1999","article-title":"Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides","volume":"67","author":"Usinger","year":"1999","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2004.07.042_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1128\/IAI.71.1.275-286.2003","article-title":"Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine","volume":"71","author":"Harris","year":"2003","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2004.07.042_bib28","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.4049\/jimmunol.154.8.4195","article-title":"Functional differences in idiotypically defined IgG1 anti- polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type b polysaccharide-protein conjugates","volume":"154","author":"Lucas","year":"1995","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2004.07.042_bib29","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1128\/IAI.71.9.5115-5120.2003","article-title":"Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice","volume":"71","author":"Jin","year":"2003","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2004.07.042_bib30","first-page":"167","article-title":"Factors influencing susceptibility to meningococcal disease during an epidemic in The Gambia","volume":"14","author":"Greenwood","year":"1987","journal-title":"West Africa. J Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2004.07.042_bib31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/JCM.22.2.152-156.1985","article-title":"Risk of group A meningococcal disease: bacterial interference and cross- reactive bacteria among mucosal flora","volume":"22","author":"Filice","year":"1985","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.07.042_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/clinids\/4.1.159","article-title":"Epidemic meningococcal disease: synthesis of a hypothetical immunoepidemiologic model","volume":"4","author":"Griffiss","year":"1982","journal-title":"Rev Infect Dis"},{"issue":"13","key":"10.1016\/j.vaccine.2004.07.042_bib33","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197709292971302","article-title":"Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age","volume":"297","author":"Peltola","year":"1977","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2004.07.042_bib34","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3201\/eid0703.017309","article-title":"Molecular epidemiology of serogroup a meningitis in Moscow, 1969 to 1997","volume":"7","author":"Achtman","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"7238","key":"10.1016\/j.vaccine.2004.07.042_bib35","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/bmj.320.7238.846","article-title":"Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study","volume":"320","author":"Neal","year":"2000","journal-title":"BMJ"},{"issue":"9157","key":"10.1016\/j.vaccine.2004.07.042_bib36","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(98)00279-7","article-title":"Uncloaking the meningococcus: dynamics of carriage and disease","volume":"353","author":"Stephens","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.07.042_bib37","first-page":"745","article-title":"Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines","volume":"81","author":"Robbins","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"10","key":"10.1016\/j.vaccine.2004.07.042_bib38","first-page":"751","article-title":"Routine vaccination with polysaccharide meningococcal vaccines is an ineffective and possibly harmful strategy","volume":"81","author":"Birmingham","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"10","key":"10.1016\/j.vaccine.2004.07.042_bib39","first-page":"752","article-title":"Conjugate meningococcal vaccines offer a much more promising alternative","volume":"81","author":"Rosenstein","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"10","key":"10.1016\/j.vaccine.2004.07.042_bib40","first-page":"753","article-title":"Control of epidemic meningitis in sub-Saharan Africa: our solution is more practical and affordable","volume":"81","author":"LaForce","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"10","key":"10.1016\/j.vaccine.2004.07.042_bib41","first-page":"754","article-title":"Successful prevention of meningitis in Africa will need more than a vaccination strategy","volume":"81","author":"Achtman","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"10","key":"10.1016\/j.vaccine.2004.07.042_bib42","first-page":"755","article-title":"Meningococcal meningitis vaccination: more information needed","volume":"81","author":"Bugri","year":"2003","journal-title":"Bull World Health Organ"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04006243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04006243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T10:22:04Z","timestamp":1682763724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04006243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0264410X04006243"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.07.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}